2,3',4,4',5'-pentamethoxystilbene
structure in first source
Also Known As:
2,3',4,4',5'-pentamethoxy-trans-stilbene
Networked: 2
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Cho, Chi Hin:
2 articles
(07/2010 - 11/2009)
|
| 2. | Li, Haitao:
2 articles
(07/2010 - 11/2009)
|
| 3. | Li, Zhi Jie:
2 articles
(07/2010 - 11/2009)
|
| 4. | Wang, Mingfu:
2 articles
(07/2010 - 11/2009)
|
| 5. | Wu, William Ka Kei:
2 articles
(07/2010 - 11/2009)
|
| 6. | Yu, Le:
2 articles
(07/2010 - 11/2009)
|
| 7. | Chan, Kam Ming:
1 article
(07/2010)
|
| 8. | Sung, Joseph Jao Yiu:
1 article
(07/2010)
|
| 9. | Wong, Clover Ching Man:
1 article
(07/2010)
|
| 10. | Ye, Cai Guo:
1 article
(07/2010)
|
Related Diseases
| 1. | Colonic Neoplasms (Colon Cancer)
11/01/2009
- " In this study, we chemically synthesized 2,3',4,4',5'-pentamethoxy-trans-stilbene (PMS), the hybrid molecule of TMS and MR-4, and determined its effects on colon cancer growth. " 07/01/2010
- " Previously, we reported that 2,3',4,4',5'-pentamethoxy-trans-stilbene (PMS), a methoxylated resveratrol derivative, exerted a highly potent anti-proliferative effect on human colon cancer cells as compared with its parent compound. " 11/01/2009
- " 2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, is a potent inducer of apoptosis in colon cancer cells via targeting microtubules."
|
| 2. | Carcinogenesis
|
| 3. | Colitis
|
|
Related Drugs and Biologics